Search Results - Chengbei Hou
- Showing 1 - 2 results of 2
-
1
Dependence of mitochondrial dysfunction in peripheral blood mononuclear cells on cervicocephalic atherosclerotic burden in acute ischemic stroke by Xiaoxi Zhao, Xiaoxi Zhao, Yi Yang, Yi Yang, Xiangying Du, Luguang Li, Luguang Li, Chengbei Hou, Yanning Cai, Yanning Cai, Xin Ma, Xin Ma
Published 2025-07-01As an inflammatory disease, atherosclerosis is associated with acute ischemic stroke (AIS), but its early identification and intervention efficacy remain suboptimal. A new research direction may be to explore peripheral atherosclerotic biomarkers from the perspective of mitochondrial dysfunction, wh...
Get full text
Article -
2
Albumin for patients with acute large-vessel occlusive stroke undergoing endovascular therapy (ARISE): the protocol of a randomized double-blind trial by Yuanyuan Liu, Xiao Dong, Xuehong Chu, Zhengfei Ma, Tingyu Yi, Tingyu Yi, Changming Wen, Yifeng Liu, Jun Sun, Jing Xu, Wenbo Li, Lei Yang, Benxiao Wang, Lei Shi, Jianqiao Li, Xiaoman Zhang, Chaoqun Li, Wenhuo Chen, Chuanhui Li, Di Wu, Chengbei Hou, Chen Zhou, Ming Li, Ming Li, Yi Xu, Chuanjie Wu, Xunming Ji, Xunming Ji
Published 2025-07-01BackgroundAlbumin is a multifunctional plasma protein that is mainly synthesized in the liver and may play a neuroprotective role in treating acute ischemic stroke (AIS). The efficacy of albumin in patients with AIS receiving reperfusion therapy remains unknown.MethodsARISE is a multicenter, randomi...
Get full text
Article